openPR Logo
Press release

Mordor Intelligence, LLP. Contributes to the Diabetes Awareness Month by Granting Free Access to Their Real-Time Exhaustive Research on Diabetes Care Drugs

11-20-2018 09:10 AM CET | Health & Medicine

Press release from: Mordor Intelligence

Mordor Intelligence

Mordor Intelligence

On the occasion of World Diabetes Awareness Month, Mordor Intelligence reiterated its commitment to helping enterprises in the business of Diabetes Care Drugs by enabling them to make smart strategic decisions. The company has announced that it is offering a full access to its Intelligence Center on the Diabetes Care Drugs for FREE. With the successful launch of this Intelligence Center last month, Mordor is already ensuring that the benefits of this data reaches all possible enterprises in this space.

The data put together by Mordor Intelligence greatly strengthens the medical community's continuous research on understanding Diabetes and the drugs used in its treatment. This market intelligence data greatly benefits enterprises in making the right decisions, by helping foster a clear understanding of the various industry trends. The company is allowing enterprises FULL ACCESS to this exhaustive and precise data related to diabetes.

This limited time Free access can be set up here: https://www.mordorintelligence.com/free-trial/diabetes-care-market

Mordor's Intelligence Center on the Diabetes Care Drugs Market offers extensive and precise data spanning 15 segments under 4 categories, covering 25 countries from 5 regions. This data is additionally backed by the brand share information of 33 brands with an R&D pipeline. A key differentiator of this platform in comparison to similar services is the accuracy and timeliness of the data. This Intelligence Center is updated every quarter with significant changes reflecting real-time information. In addition, the platform is extremely user-friendly and offers a seamless, intuitive experience. In addition to Intelligence on Diabetes Care Drugs, Mordor also offers a comprehensive Intelligence Center on Diabetes Care Devices.

The coverage offered is as listed:

CATEGORIES & SEGMENTS

Insulin
Basal Insulin
Bolus Insulin
Human Insulin
Human Insulin Inhaled
Non-Insulin Injectables
Amylin Analogue
GLP-1 Agonist
Oral Antidiabetic Drugs
Alpha Glucosidase Inhibitors
Biguanides
Dopamine - B2 receptor agonist
DPP-4 Inhibitors
Meglitinide
SGLT-2 Inhibitors
Sulfonylureas
Combination Drugs
Insulin Combination
Oral Combination

REGIONS & COUNTRIES

Asia Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
South Korea
Thailand
Vietnam
Europe
France
Germany
Italy
Russia
Spain
United Kingdom
Latin America
Brazil
Mexico
North America
Canada
United States
Middle East
Egypt
Iran
Oman
Saudi Arabia
South Africa

BRANDS

Afrezza
Apidra
Basaglar
Bydureon
Byetta
Cycloset
Farxiga/Forxiga
Galvus
Generic
Humalog
Humulin
Insuman
Invokana
Janumet
Januvia
Jardiance
Lantus
Levemir
Lyxumia
Novolin/Human Insulin
Novolog/NovoRapid
NovoMix
Onglyza
Ryzodeg
Suglat
Symlin
Toujeo
Tradjenta
Tresiba
Trulicity
Victoza
Vipidia/Nesina
Xultophy

Mordor Intelligence, LLP. operates in the business of industry analysis & consulting, helping clients shape their strategic decisions. Founded in 2013, and fully revenue-funded, Mordor is based out of Hyderabad, India. The company offers custom market intelligence and advisory services along with syndicated reports to help customers gain the edge over the competition. Mordor caters to over 500 clients across the globe in various industries. (www.mordorintelligence.com)

MEDIA CONTACT

Name: Sameeksha Bansal
Email: sameeksha@mordorintelligence.com
Phone: +1-617-765-2493

Address- Mordor Intelligence
Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
India

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Mordor Intelligence, LLP. Contributes to the Diabetes Awareness Month by Granting Free Access to Their Real-Time Exhaustive Research on Diabetes Care Drugs here

News-ID: 1377096 • Views:

More Releases from Mordor Intelligence

Freighter Aircraft Market Driven by Rising E-commerce Logistics and Global Trade Expansion - Mordor intelligence
Freighter Aircraft Market Driven by Rising E-commerce Logistics and Global Trade …
Introduction According to a recent report by Mordor Intelligence, the market is expected to reach roughly USD 6.95 billion in 2025 and climb to around USD 9.19 billion by 2030 at a CAGR of 5.76%. The freighter aircraft market is experiencing steady growth as global trade and e-commerce continue to surge. These aircraft play a critical role in enabling the rapid movement of high-value and time-sensitive goods across continents. Both purpose-built
Bioabsorbable Stent Market to Reach USD 813.08 million by 2030 Driven by Rising Cardiovascular Interventions and Preference for Biocompatible Solutions
Bioabsorbable Stent Market to Reach USD 813.08 million by 2030 Driven by Rising …
Mordor Intelligence has published a new report on bioabsorbable stents market offering a comprehensive analysis of trends, growth drivers, and future projection-Mordor intelligence Introduction The bioabsorbable stents market size stands at USD 497.59 million in 2025 and is projected to reach USD 813.08 million by 2030, translating into a 10.32% CAGR over the forecast period. The growth reflects a sustained rise in minimally invasive cardiovascular procedures and a clear
Anthrax Vaccine Market is Projected to Reach USD 9.13 billion by 2030, Driven by Rising Bioterrorism Threats and Military Applications
Anthrax Vaccine Market is Projected to Reach USD 9.13 billion by 2030, Driven by …
Mordor Intelligence has published a new report on anthrax vaccine market" offering a comprehensive analysis of trends, growth drivers, and future projection-Mordor intelligence Introduction: The anthrax vaccine market is valued at USD 5.98 billion in 2025 and is forecast to reach USD 9.13 billion by 2030, advancing at a 7.30% CAGR. The anthrax vaccine market has gained substantial traction over recent years due to the increasing need for disease prevention
Anticoagulant Reversal Drugs Market to Reach USD 2.69 billion by 2030, Driven by Emergency Care Demand
Anticoagulant Reversal Drugs Market to Reach USD 2.69 billion by 2030, Driven by …
Introduction: The anticoagulant reversal drugs market size reached USD 1.51 billion in 2025 and is forecast to attain USD 2.69 billion by 2030, advancing at a 12.15% CAGR. The growth reflects a global healthcare shift toward managing bleeding complications linked to anticoagulant therapies. As the use of direct oral anticoagulants (DOACs) continues to rise for conditions like atrial fibrillation, deep vein thrombosis, and pulmonary embolism, hospitals and emergency departments

All 5 Releases


More Releases for Insulin

Advancing Insulin Delivery Systems boost the Global Insulin Path Pumps Market
Inkwood Research expects the Global Insulin Patch Pumps Market to surge with a 10.63% CAGR by 2032, and is set to generate $2760.98 million during the forecast period 2023-2032. Browse 50 market data Tables and 47 Figures spread over 173 Pages, along with an in-depth analysis of the Global Insulin Patch Pumps Market by Type, Delivery Mode, Disease Indication, Distribution Channel, & by Geography. Refer to the Report Summary Here: https://inkwoodresearch.com/reports/insulin-patch-pumps-market/#report-summary This insightful
Advancing Insulin Delivery Systems boost the Global Insulin Path Pumps Market
Inkwood Research expects the Global Insulin Patch Pumps Market to surge with a 10.63% CAGR by 2032, and is set to generate $2760.98 million during the forecast period 2023-2032. Browse 50 market data Tables and 47 Figures spread over 173 Pages, along with an in-depth analysis of the Global Insulin Patch Pumps Market by Type, Delivery Mode, Disease Indication, Distribution Channel, & by Geography. Refer to the Report Summary Here: https://inkwoodresearch.com/reports/insulin-patch-pumps-market/#report-summary This insightful
Advancing Insulin Delivery Systems boost the Global Insulin Path Pumps Market
Inkwood Research expects the Global Insulin Patch Pumps Market to surge with a 10.63% CAGR by 2032, and is set to generate $2760.98 million during the forecast period 2023-2032. Browse 50 market data Tables and 47 Figures spread over 173 Pages, along with an in-depth analysis of the Global Insulin Patch Pumps Market by Type, Delivery Mode, Disease Indication, Distribution Channel, & by Geography. Refer to the Report Summary Here: https://inkwoodresearch.com/reports/insulin-patch-pumps-market/#report-summary This insightful
Insulin Pumps Market Share, Trends and Growth Analysis By Type (Traditional Insu …
Insulin Pumps Market is expected to register a CAGR of 15.5% and acquire the market value of USD 11.5 Billion by 2028 during forecast period 2023-2032. Insulin pumps are discreet, electronic medical devices that can be tucked beneath clothing or fastened to a belt. In order to regulate the rise in blood glucose levels, the pump is used to deliver controlled quantities of insulin within the body at regular intervals
Insulin Patch Pumps Market Report 2018: Segmentation by Insulin Type (Bolus Insu …
Global Insulin Patch Pumps market research report provides company profile for Roche Holding AG, Cellnovo Group SA, Spring Health Solution Ltd., Debiotech, CeQur SA, Valeritas, Becton Dickenson & Company, Insulet Corporation, Johnson & Johnson, Medtrum Technologies Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue,
Insulin pump Market Explore Future Growth 2018-2026 by Global Type-Traditional i …
Insulin pump is a portable device attached to the body that continuously delivers preset amounts of short or rapid acting insulin in the body to control diabetes. Insulin therapy is required in type 1 diabetes and sometime in type 2 diabetes. It serves as an effective alternative to insulin injections. Furthermore, insulin pump delivers the insulin according to the need of body as basal rate, where small amount of insulin